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Case Reportssmall intestinal submucosa ECMgrafts.1-2 Althoughwe have
not shown cellular regeneration, our findings of contractile
activity support the continued use and study of CorMatrix
ECM cardiac repair.
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Thorac Surg. 1995;59:403-7.Staged total aortic hybrid repair for DeBakey type I dissection:
Report of a caseMarco Di Eusanio, MD, PhD, Paolo Berretta, MD, Luigi Lovato, MD, and Roberto Di Bartolomeo, MD,
Bologna, ItalyOpen surgical repair for extensive aortic disease represents
a great challenge, and staged approaches involving multiple
hybrid procedures have emerged as an appealing alternative
to conventional open repair.1 We report a case of DeBakey
type I aortic dissection treated with a total aortic repair
through a staged hybrid approach.CLINICAL SUMMARY
A 45-year-old man who had undergone a Bentall proce-
dure for an acute DeBakey type I aortic dissection
(Figure 1, A-C) 7 years previously was referred to our insti-
tution. Computed tomographic scan (Figure 1, D-F) docu-
mented a chronic postdissection aneurysm of the aortic
arch and thoracoabdominal aorta (70 mm) with proximal
entry tears at the brachiocephalic trunk and aortic isthmus.
At the descending thoracic aorta, the true lumen was nar-
row (4 mm) and circumferentially dissected; multiple
reentry tears were located in the distal aorta, and all
visceral vessels originated from the true lumen except for
the right renal artery. A staged hybrid approach was
offered. The patient initially underwent a complete arch
replacement with a wide fenestration of the descending
intimal flap and elephant trunk construction. The arch ves-
sels were reimplanted by means of the separate grafttechnique with a 28-mm Siena 4-branched aortic graft
(Vascutek Ltd, Glasgow, Scotland; Figure 1, G-I). Ante-
grade selective cerebral perfusion with moderate hypother-
mia was used for cerebral protection.2 Two months later,
graft replacement (28 mm) of the descending thoracic aorta
was performed with temporary left heart bypass, sequential
clamping, and cerebrospinal fluid drainage for spinal and
visceral protection (Figure 1, J-L). Four months later, the
patient was readmitted for treatment completion of the re-
sidual thoracoabdominal aortic aneurysm. Through a me-
dian laparotomy with a transperitoneal approach, the
infrarenal abdominal aorta was replaced and the visceral
vessels were revascularized with a 28-mm multi-
branched Coselli thoracoabdominal graft (Vascutek). Se-
lective renal perfusion with cold crystalloid solution was
used for renal protection (Figure 2, A-D). During the
same hospitalization, endovascular exclusion of the re-
maining thoracoabdominal aorta was then performed; 2
Valiant Medtronic stent-grafts (34-36 mm) were implanted
with a 20% to 30% oversizing. Graft-to-graft overlaps of 4
and 3 cm were achieved in the proximal and distal landing
zones, respectively. Cerebrospinal fluid drainage was
applied for spinal cord protection. The predischarge
computed tomographic scan showed a total aortic replace-
ment with a partially thrombosed false lumen as a result of
residual endograft porosity (Figure 2, E-H). All postopera-
tive courses were totally uneventful. At 6-month follow-up,
the patient remains well, with unchanged aortic appear-
ances and stable aortic diameters.DISCUSSION
Reoperations for extensive open aortic replacement are
associated with considerable morbidity and mortality. Dur-
ing the last decades, hybrid and endovascular repairrdiovascular Surgery c Volume 147, Number 4 e43
FIGURE 1. Multidetector computed tomographic axial (A,D, G, and J), longitudinal (B, E,H, andK), and 3-dimensional (C, F, I, and L) images. A-C,Onset
of DeBakey type I aortic dissection. D-F, Residual chronic postdissection aneurysm of the aortic arch and thoracoabdominal aorta (70 mm), with narrow and
circumferentially dissected false lumen at the descending thoracic aorta, 7 years after Bentall procedure. G-I, Predischarge computed tomographic scan after
complete arch replacement with fenestration of the descending intimal flap and elephant trunk construction. The white arrows indicate the free-floating
segment of the elephant trunk. J-L, Predischarge computed tomographic scan after open replacement of two thirds of the descending aorta.
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FIGURE 2. Multidetector computed tomographic longitudinal (A and E), 3-dimensional (B, C, and F), and axial (D, G, and H) images. A-D, Computed
tomographic scan after replacement of the infrarenal abdominal aorta and debranching of visceral vessels. E-H, Final computed tomographic scan after the
5-stage hybrid aortic repair. The entire native aorta, from root to iliac bifurcations, has been replaced.
Case Reportstechniques have emerged as interesting alternative options
for high-risk patients.1 We have described a successful
case of a 5-stage total aortic hybrid repair.
Of note, after complete arch replacement with elephant
trunk, endovascular repair of descending thoracic aorta
was excluded, and an open replacement of two thirds of
the descending aorta was performed instead. In fact, the
extremely narrow and concentric true lumen (Figure 1, AThe Journal of Thoracic and Caand D) would not have ensured a safe and fully open
stent-graft deployment and would have carried a high risk
of uncontrolled laceration of the distal intimal lamella.
For abdominal aortic replacement and visceral vessel de-
branching, a prefabricated 4-branched Dacron polyester
fabric graft was used. Relative to separate grafts for the
branch arteries, this prosthesis, designed for revasculariza-
tion of visceral vessels, can greatly simplify abdominalrdiovascular Surgery c Volume 147, Number 4 e45
Case Reportsaortic debranching by reducing both the number of anasto-
moses and the risk of bleeding.
Neurologic protection is a main concern during arch and
thoracoabdominal aortic procedures. If antegrade selective
cerebral perfusion has already shown to be the best method
of brain protection,2 more recent experimental and clinical
studies have introduced the collateral network concept to
comprehend spinal vascular remodeling after extensive
thoracoabdominal aortic interventions. This notion indi-
cates that restoring a good spinal cord perfusion is a
time-dependent process and supports staged thoracoabdo-
minal aortic repair to reduce the incidence of postoperative
spinal cord injury.3 Furthermore, relative to single-staged
procedures, which combine at once the detrimental effects
of visceral ischemia with those of nephrotoxic contrast
media, staged repair seem to be associated with reduced
postoperative renal failure rates and shorter hospital stay.4
We were well aware that a patient’s failure to complete
treatment (as result of death while waiting or refusal) repre-
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vide treatment into fractions carrying less impact.
In conclusion, a staged hybrid approach for total aortic
repair is feasible and can represent a valid form of treatment
for selected patients with extensive aortic disease. It may
help reduce morbidity and mortality among these high-
risk patients.
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for implantable left ventricular assist device replacement casesMatthew A. Schechter, MD,a Chetan B. Patel, MD,b Joseph G. Rogers, MD,b and Carmelo A. Milano, MD,a
Durham, NCReplacement of an implantable left ventricular assist device
(LVAD) may be required for infection, thrombosis, or me-
chanical or electrical failure.1,2 In certain instances,
replacement of implantable LVADs poses a very high risk
of either reinfection or death. This report describes 4
cases in which implantable LVADs required urgent
removal but replacement of an implantable system was
delayed by a period of support with an extracorporeal
temporary device.CLINICAL SUMMARY
The first patient was a 58-year-old woman with
ischemic cardiomyopathy who had received a HeartMate
II (Thoratec Corporation, Pleasanton, Calif) as destination
therapy. The patient presented approximately 18 months
after implantation with persistent bacteremia and medias-
tinal purulence. Echocardiography showed vegetation
around the inflow cannula. The decision was made to re-
move the device. Because of the extent of infection, the
patient was supported with an extracorporeal device (Para-
corporeal Ventricular Assist Device [PVAD]; Thoratec)
while receiving antibiotic therapy. After 3 weeks of antibi-
otics, the patient had negative results of blood cultures and
a normal white blood cell count. She was returned to the
operating room, where the Thoratec PVAD was replaced
with another HeartMate II device. The patient did well
postoperatively and went on to live for approximately 3
years without any further episodes of bacteremia or other
evidence of device infection.
The second patient was a 63-year-old man who
presented with recurrent fevers and staphylococcal bacter-
emia despite intravenous antibiotics 1 year after receivingery c April 2014
